semaglutide in kidney disease FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction the risk of disease-related events in people with type 2 diabetes and chronic kidney compared to placebo. Investigators Add-On, Not Replacement: Semaglutide's Role
Description
Clean the injection site with an alcohol swab, and inject subcutaneously
this decision can only be made by a medical professional after consultation and cautious examination in the hospital
While the findings are observational and most participants in the study were older white men with diabetes, which could limit how broadly the results apply to other groups, experts not involved in the study said they provide a helpful big-picture view
Possibly, but not always directly
Does GLP-1 Help With Rheumatoid Arthritis
Create a Sterile Field: Clean your work surface thoroughly
